Global Genes’ RARE Patient Advocacy Summit

  • Post author:
  • Post category:

The Global Genes RARE Patient Advocacy Summit This conference will be a convergence of a variety of rare disease stakeholders, such as rare disease patients, world renowned experts, and caregivers.…

Continue Reading Global Genes’ RARE Patient Advocacy Summit
Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Free-Photos / Pixabay

Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says

According to a story from Medscape, a recent study is highlighting the fact that many thyroid cancer survivors are still worried about cancer-related problems years after the conclusion of treatment.…

Continue Reading Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1
RoyBuri / Pixabay

Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1

According to a story from wearegreenbay.com, a team of scientists associated with the University of Wisconsin, Madison are undertaking a project that will help improve the effectiveness of research related…

Continue Reading Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1
Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy
mwooten / Pixabay

Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from newswise.com, the American Neuromuscular Foundation has recently awarded a grant to Dr. Karissa Gable. This grant will go towards a research project headed by Dr.…

Continue Reading Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy

This Company Just Announced Plans to Develop a Gene Therapy for Type 2A Charcot-Marie-Tooth Disease

According to a story from BioSpace, the genetic medicines company Passage Bio recently announced plans for its sixth program for gene therapy development. The company plans to work with the…

Continue Reading This Company Just Announced Plans to Develop a Gene Therapy for Type 2A Charcot-Marie-Tooth Disease
New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups
truthseeker08 / Pixabay

New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups

According to a story from journals.lww.com, The Lazarex Cancer Foundation and the University of California San Francisco have announced plans to work together on a three year study that will…

Continue Reading New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups

An Experimental Drug Could be Effective for Neuromyelitis Optica, Study Results Show

According to a story from Biotech 365, the biotechnology company Viela Bio announced the publication of critical results from a recent study that tested the company's investigational drug inebilizumab as…

Continue Reading An Experimental Drug Could be Effective for Neuromyelitis Optica, Study Results Show
This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
jarmoluk / Pixabay

This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?

According to a story from Forbes, a new drug developed by the company Regeneron has the potential to make a real difference for people with the homozygous form of familial…

Continue Reading This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease
katicaj / Pixabay

A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease

According to a story from rheumatology.medicinematters.com, a recent Italian real-world study has provided some evidence that the drug apremilast, which is considered a phosphodiesterase-4 inhibitor, could be a useful treatment…

Continue Reading A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease

Patients in Mayo Clinic’s RIGHT Study Carried One or More Genetic Variants That May Affect Their Response to Medication

  Pharmacogenomics plays an important role in predicting whether patients will benefit from certain medications or if the medication will cause serious side effects. The process involves the way in…

Continue Reading Patients in Mayo Clinic’s RIGHT Study Carried One or More Genetic Variants That May Affect Their Response to Medication